Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D010869:Pindolol / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D011985:Receptors, Serotonin / Q000187:drug effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D010869:Pindolol; D011943:Receptors, Adrenergic, beta; D011985:Receptors, Serotonin; D017367:Selective Serotonin Reuptake Inhibitors